Literature DB >> 1414484

Influence of oophorectomy on serum levels of sex steroids and bone metabolism and assessment of bone mineral density in lumbar trabecular bone by QCT-C value.

H Ohta1, K Makita, Y Suda, T Ikeda, T Masuzawa, S Nozawa.   

Abstract

The present cross-sectional study was carried out to determine the influence of oophorectomy (OPX) on serum levels of sex steroids and bone metabolism, as well as bone mineral density (BMD), in OPX subjects in comparison with age- and body size-matched controls. Quantitative computed tomography (QCT) and dual-photon absorptiometry (DPA) demonstrated a remarkable reduction in BMD in OPX subjects. In particular, the QCT of the centrum of vertebral bone (QCT-C) in these subjects was no more than 69.33 +/- 3.40% (X +/- SEM) of the control value, and this parameter was much lower than the QCT integral (QCT-I) value of total lumbar vertebrae. This means that BMD decreases specifically in spongy portions after OPX. The serum level of estrone (E1) was significantly lower in OPX subjects than in controls. The hormonal action of E1 on target organs has been thought to be only one-third of that of estradiol (E2), but the marked reduction in serum E1 level seemed to be a significant cause of the reduction in BMD. The serum level of androstenedione (delta 4) significantly decreased in OPX subjects and appeared to affect bone metabolism negatively. Both bone formation and bone resorption were found to be stimulated following OPX, but the rate of bone resorption was found to be higher than that of bone formation: there was an imbalance between bone formation and bone resorption in OPX subjects. However, it was not possible to prove a relationship between Ca regulating hormone and this phenomenon. In conclusion, the QCT-C value reflects the changes in spongy vertebral BMD more sensitively than the QCT-I value or DPA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414484     DOI: 10.1002/jbmr.5650070610

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  The effect of bilateral oophorectomy on bone mineral density.

Authors:  Alper Hayirlioglu; Hüsnü Gökaslan; Nurten Andaç
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

2.  The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.

Authors:  R Balena; B C Toolan; M Shea; A Markatos; E R Myers; S C Lee; E E Opas; J G Seedor; H Klein; D Frankenfield
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

3.  Effects of Sigma Anti-bonding Molecule Calcium Carbonate on bone turnover and calcium balance in ovariectomized rats.

Authors:  So-Young Choi; Dongsun Park; Goeun Yang; Sun Hee Lee; Dae Kwon Bae; Seock-Yeon Hwang; Paul K Lee; Yun-Bae Kim; Ill-Hwa Kim; Hyun-Gu Kang
Journal:  Lab Anim Res       Date:  2011-12-19

4.  Specific nephrotoxicity and cardiotoxicity of BT-CAL®, Sigma Anti-bonding Molecule Calcium Carbonate, in mice.

Authors:  Ja-Young Jang; Jingmei Cai; Jihyun Kim; Jangbeen Kyung; Dajeong Kim; Ehn-Kyoung Choi; Youngeun Kim; Kwang-Sei Kim; Dongsun Park; Hyun-Gu Kang; Yun-Bae Kim
Journal:  Lab Anim Res       Date:  2013-03-25

5.  Aging and estrogen status: a possible endothelium-dependent vascular coupling mechanism in bone remodeling.

Authors:  Rhonda D Prisby; James M Dominguez; Judy Muller-Delp; Matthew R Allen; Michael D Delp
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

6.  Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women.

Authors:  Keina Nishio; Akiko Tanabe; Risa Maruoka; Kiyoko Nakamura; Masaaki Takai; Tatsuharu Sekijima; Satoshi Tunetoh; Yoshito Terai; Masahide Ohmichi
Journal:  Endocr Connect       Date:  2012-11-19       Impact factor: 3.335

7.  Bone loss in the ovariectomized baboon Papio ursinus: densitometry, histomorphometry and biochemistry.

Authors:  I Dal Mas; A Biscardi; C M Schnitzler; U Ripamonti
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.